The document discusses best practices for verification and validation documentation. It covers topics like design verification and validation, design history files, process verification and validation, common issues found by regulators, and strategies for addressing issues. Key points emphasized include properly documenting design controls, validation procedures, change controls, sampling methods, and being prepared for potential FDA audits. The document provides guidance on standardizing test method documentation and understanding validation lifecycles and expectations of regulatory bodies.
2. Best Practices in making sure that
verification and validation
documentations are well understood
Rommel B. Garcia
Consultant Project Manager
3. So you think you are intelligent and
you think you are right!
Well, guess what, someone else
think that you are wrong!
Mr.
OPinion
4. A company in the past thru a recruiter
call me and wanted to engage.
The companys name is:
I will not tell
They suffered several Major
Observation
5. 1. DESIGN VERIFICATION AND VALIDATION
Failure to establish and maintain adequate procedures for verifying the
device design.
Design verification shall confirm that the design output meets the design
input requirements, as required by 21 CFR 820.30
2. DESIGN HISTORY FILE
Failure to establish and maintain a design history file for each type of
device, as required by 21 CFR 820.30
3. PROCESS VERIFICATION AND VALIDATION :
Failure to ensure, when the results of a process cannot be fully verified by
subsequent inspection and test, that the process shall be validated with a
high degree of assurance and approved according to established
procedure, as required by 21 CFR 820.75 (a)
Failure to establish procedures for monitoring and control of process
parameters for validated processes to ensure that the specified
requirements continue to be met, as required by 21 CFR 820.75(b).
6. A follow up inspection will be required to assure that correction and/or corrective actions
are adequate. Your firm should take prompt action to correct the violations addressed in this
letter.
Failure to promptly correct these violations may result in regulatory action being initiated
by the FDA without further notice.
These actions include, but are not limited to, seizure, injunction, and/or civil
money penalties.
Also, federal agencies may be advised of the issuance of Warning Letters about devices
so that they may take this information into account when considering the
awarding of contracts.
Additionally, premarket approval applications for the Class of devices to which the
Quality System regulation violations are reasonably related to will not be approved
until the violations have been corrected.
7. An Accident?
Paper Trail
Not properly documented
Missing documents
No SOP
Assessment
Weak internal auditing practices
Documents not defendable
8. Identification of Gaps
Standardization Practice
Relearn Design Control
The Risks
What is CTQ and CQA
Statistical Techniques
Proper use of Lexicons
Definitions V&V
What is in V&V
Understanding when to verify and when to
validated
SOP
Test Method Validation & MSA
Documentations
Stages
DHF
The Regulatory Body
10. User
Needs
Concept Phase
- VOC information
- IDE
- Concept Study
- Clinical/Animal Studies
- VOC Design Review
- Intended Use
Design Input
DDP & Product
Requirements
Feasibility Definition Phase
- Design Development Plan
- Design Input Requirements
- Risk Management
- Design Reviews
Design Development Process
Design
Review
Design Output
Medical Device
Development Phase
- Design outputs created (Specifications /
Drawings / MSA / Test Methods Validation /
DVT (Design Verification Test), Supplier
Verification / Validation & Approval / etc.)
- Design Reviews
Device Qualification Phase
- Packaging / Sterility Ver. & Val.
- Device / Design Validation
- Process Validation
- DMR/DHR
- Design Transfer / Review
- Review and update Risks
- Shelf Life Verification/Study
- Design Freeze
- R/A Submissions / Approval
Product Closure Product Launch
Product Launch
- Post-Market Surveillance
- Production Review
- Return Analysis, RMR/RCA
as Needed
- Review and update RMF
- Release product for sale ECO
- Equipment / System Validation
END of Life - Decommissioning
Device Validation
D.V.T.
11. Why are we talking about Risk.
It is part of the QMS
ISO14971
Is the How to identify the hazard associated with the device
Estimate the risk associated with the hazard
Risk Management Processes Elements
Risk Identification / Analysis
Risk Evaluation
Risk Control
Risk Assessment
12. CTQ - are key measurable characteristics of a component or process whose performance
standards or specification limits that must be met in order to satisfy the customer requirement
CQA - a physical, chemical, biological or microbiological property or characteristic that shall
be within an appropriate limit, range, or distribution in order to ensure the desired product
quality.
Therefore:
The purpose of CTQ is to convert user needs to a measurable requirement (Specification)
While the purpose of CQA is to convert the CTQ further for business to implement in manufacturing.
SO:
CTQ is in the Design Control stage and the CQA is in the Manufacturing stage.
Ref:
Early,J.F. and O.Coletti. Section 3: The Quality Planning Process. Jurans Quality Handbook. 5thEd. 1999
13. When do we use the following words:
Shall
Should
May
Quiz
Which of the statements is correct:
1. We may follow all the regulation in 21CFR 820
when we produce or manufacture medical
device.
2. We shall follow our companys Quality System
Regulation.
3. We should invest in our companys 401K
14. Verification is looking for an objective evidence that the
product (which is a widget) is being produced correctly.
Validation is looking for objective evidence that the widget is
the correct product
15. Activities in:
Verification
Worst Case Analysis
Thermal Analysis
Fault Tree Analysis
Package Integrity Analysis
Biocompatibility Analysis
Bioburden Analysis
Leveraging
Validation
Types
Validation of Process
Validation of Test Methods
Validation of Equipment
Documents
Validation Planning VMP
Validation Protocol
Validation Report
Documentation
Repository
16. An Example:
Adhesive Material
When is verification
applicable and when is
validation applicable
17. Subpart O or 820.250
Requires manufacturers to establish and maintain procedures for
identifying valid statistical techniques
Sampling Plans
Attribute: N=ln(1-CL)/lnR
Variable: n=3/P
Capability Analysis
Statistical Analysis
others
18. Failure to document how to review sampling methods for adequacy for their
intended use, as required by 21 CFR 820.250(b).
Do what you say, Say what you do:
One thing leads to another.
Why do we need an SOP?
The Purpose
The Command
How do we make it Compliant?
Compliance/Training Team
The Task
Review
Distribution
Training
Metrics
19. Definitions
Difference between TVM and MSA
Not much
Deliverables
Accuracy
Precision
Repeatability
Reproducibility
Specificity
Sensitivity
Linearity
But why do we do it?
20. Contents of Design History File
The contents will probably vary from class to class, company to company and
from industry to industry
In general, the contents should be:
Design Development Plans
Design Input Documentations
Design Risk Documentation and Pointers (RMF)
Design Output Documentations
Design Reviews Documentations
Design Verification Documentations
Design Validation Documentations (including Shelf Life)
Design Trace Matrices Documentations
Design Transfer Documentation
Change Control Documentations
21. An FDA Audit probability
What will they look for..
Design Control SOP
Did you properly audit your documents against the QSR
Did I we do a good sample
Change Controls
Do we have any changes
What is common sense in changes
What is LESLI (LESsons Learned Index)
Why
Sampling Metrics
22. What do they normally do?
Sequence
Why
Quality System
MDR / Complaints / Adverse Events
CAPA
Trending
QSIT
Probability High
DHF
Documents
Trace Matrices?
Questions and documentations
Are you ready?
These are all valid concerns and expectation from FDA
23. When put all of the items together:
Test Methodologies how do we standardized the
configuration of documenting them
We have discussed the Test Method Validation and
MSA
What are the critical requirements that should be met
We have also discussed the background statistics
What does the regulatory body expects from
Verification and Validation records
We have discussed an experience that I had when
one of the company that got a warning letter and
the activities that we did to remediate.
In the last slide, I have given you example of what
FDA will possibly ask so take note
Validation lifecycle documentation multiphasic process
We have discussed the different elements of
validation with respect to Design Control and the
phases involved.
24. PLEASE BE KIND TO ANIMALS LIKE ME
For more questions please send me email me:
melmaan2010@gmail.com